Sullivan, Lynn E., Brent A. Moore, Marek C. Chawarski, Michael V. Pantalon, Declan Barry, Patrick G. O'Connor, Richard S. Schottenfeld, and David A. Fiellin. "Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors." Journal of substance abuse treatment 35, no. 1 (2008): 87-92.